Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationMHRA have produced a new 'Guidance on the licensing of biosimilar products'.
The International Council for Harmonisation (ICH) E6 on Good Clinical Practice (GCP) is currently undergoing a major revision.
With the move to electronic ways of working and integration of more electronic systems within a clinical trial, the MHRA GCP inspectorate has noticed that not all eSystems have been designed with the correct functionality in mind.
This month EMA’s safety committee (PRAC) reviewed a number of safety signals related to COVID-19 vaccines. The evaluation of safety signals is a routine part of pharmacovigilance and is essential to ensuring that regulatory authorities have a comprehensive knowledge of a medicine’s benefits and risks.
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 April 2021
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 April 2021
FDA Authorises Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer. Medical device aids clinicians in detecting potential irregularities during colon cancer screening and surveillance
Regulatory status of equipment being used to help prevent coronavirus (COVID-19) - addition of section about transparent facemasks
Available to view now on YouTube.
FDA have published their Bioresearch Monitoring (BIMO) Fiscal Year 2020 Metrics